Issue of Equity and Total Voting Rights

RNS Number : 0578V

Circassia Pharmaceuticals Plc

18 July 2018

 

            18 July 2018

Circassia Pharmaceuticals plc

Issue of Equity and Total Voting Rights

Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) announces that, further to the announcement made on 16^th July 2018, 23,725,800 Ordinary Shares have been admitted to the premium listing segment of the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities (together, "Admission").

In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, Circassia confirms that the Company's issued share capital consists of 357,192,062 Ordinary Shares, each with equal voting rights. No shares are held in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure and Transparency Rules.

For further information, please contact:

Circassia Pharmaceuticals plc

Julien Cotta, Company Secretary [phone]

 

END

 

 

MSCEAAXPFSFPEFF